PDE5 inhibition restores mitochondrial function and improves neurobehavioral outcomes after repeated mild blast TBI
Madison O. Kilgore, Shaojing Ye, Felix Oyelami, Alaa Alareidi, Jaycie Gard, Lance A. Johnson, Gopal V. Velmurugan, W. Brad Hubbard · 2026
Read PDE5 inhibition restores mitochondrial function and improves neurobehavioral outcomes after repeated mild blast TBI by Madison O. Kilgore, Shaojing Ye, Felix Oyelami, Alaa Alareidi, Jaycie Gard, Lance A. Johnson, Gopal V. Velmurugan, W. Brad Hubbard (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13627102.txt.
Description
Madison Kilgore and co-authors tested a familiar drug as a treatment for repeated mild blast brain injury in rats, in a 2026 study. Soldiers exposed to blasts can carry lasting thinking and mood problems, and no approved drug helps. The drug, sildenafil, blocks an enzyme called PDE5. The team gave two mild blasts a day apart, then daily drug doses started either right after or eight weeks later.
Blasts drained the brain's energy factories and left fuel half-burned. The drug restored a master switch for building new energy factories and eased the fuel jam. It also revived the energy output of tiny brain blood vessels under stress. Behavior told the same story: anxiety after injury eased, and at twenty weeks the treated rats let go of learned fear more readily. The authors back the drug for trials in blast injury.
Catalog record
| CREATOR | Madison O. Kilgore, Shaojing Ye, Felix Oyelami, Alaa Alareidi, Jaycie Gard, Lance A. Johnson, Gopal V. Velmurugan, W. Brad Hubbard |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 86 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |